Rifapentine use while Breastfeeding

Rifapentine Levels and Effects while Breastfeeding

Summary of Use during Lactation

The amount of rifapentine in milk is insufficient to treat tuberculosis in the breastfed infant. The Centers for Disease Control and Prevention and other professional organizations state that breastfeeding should not be discouraged in women taking rifapentine.[1][2][3]

Drug Levels

Maternal Levels. Relevant published information was not found as of the revision date.

Infant Levels. Relevant published information was not found as of the revision date.

Rifapentine Identification

Substance Name

Rifapentine

CAS Registry Number

61379-65-5

Drug Class

Antitubercular Agents

Leprostatic Agents

Rifamycins

Administrative Information

LactMed Record Number

705

Last Revision Date

20130907

Disclaimer

Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.

Disclaimer: This information is not intended as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. Use of this website signifies your agreement to the Terms of Use and Online Privacy Policy.